Debiovision’s Sanvar Will Be Tough Sell To Advisory Panel

FDA has declared any positive results from a study of vapreotide to be statistically insignificant, immeasurably biased and possibly due to the endoscopic therapy rather than the drug.

More from Archive

More from Pink Sheet